Author:
Taga Takashi,Imamura Toshihiko,Nakashima Kentaro,Maeda Naoko,Watanabe Akihiro,Miyajima Yuji,Sakaguchi Sachi,Sano Hitoshi,Hasegawa Daiichiro,Kawasaki Hirohide,Adachi Souichi,Takagi Masatoshi,Koh Katsuyoshi,Manabe Atsushi,Taki Tomohiko,Ishida Yasushi
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Swerdlow SH, Campo E, Harris NL, Pileri S, Stein H, Jaffe ES. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008. p. 140.
2. Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, et al. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. J Clin Oncol. 2009;27:4007–13.
3. Taga T, Shimomura Y, Hori T, Horikoshi Y, Ogawa A, Itoh M, et al. A morphology-based approach for the treatment of children with acute myeloid leukemia: a report from the Japanese Children’s Cancer and Leukemia Study Group AML 9805 Study. Jpn J Pediatr Hematol. 2010;24:283–91.
4. Tomizawa D, Tawa A, Watanabe T, Saito AM, Kudo K, Taga T, et al. Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children. Leukemia. 2013;27:2413–6.
5. Bisschop MM, Revesz T, Bierings M, van Weerden JF, van Wering ER, et al. Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia. Leukemia. 2001;15:46–9.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献